Konferenzbeitrag
Reference pricing and cost-sharing: Theory and evidence on German off-patent drugs
This paper evaluates the impact of reference pricing on prices and co-payments in the (German) market for off-patent pharmaceuticals. We present a theoretical model with price-sensitive and loyal consumers that shows that a decrease in the reference price affects the consumers' co-payments in a non-monotonic way: For high reference prices, a marginally lower reference price may lead to lower co-payments. However, for low reference prices a further reduction may result into higher consumer co-payments. We use quarterly data on reference priced drugs covered by the social health insurance in Germany over the period 2007 - 2010 to analyze the empirical effects of reference price reductions. We find that, while prices decrease due to the reduction, co-payments behave non-monotonically and indeed increase if the reference price is sufficiently low.
- Sprache
-
Englisch
- Erschienen in
-
Series: Beiträge zur Jahrestagung des Vereins für Socialpolitik 2014: Evidenzbasierte Wirtschaftspolitik - Session: Health III ; No. C10-V1
- Klassifikation
-
Wirtschaft
Health: Government Policy; Regulation; Public Health
Analysis of Health Care Markets
Oligopoly and Other Imperfect Markets
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Herr, Annika
Stühmeier, Torben
Wenzel, Tobias
- Ereignis
-
Veröffentlichung
- (wer)
-
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften, Leibniz-Informationszentrum Wirtschaft
- (wo)
-
Kiel und Hamburg
- (wann)
-
2014
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:42 MEZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzbeitrag
Beteiligte
- Herr, Annika
- Stühmeier, Torben
- Wenzel, Tobias
- ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften, Leibniz-Informationszentrum Wirtschaft
Entstanden
- 2014
Ähnliche Objekte (12)
Cost sharing, capacity investment and pricing in networks
More cost-sharing, less cost? Evidence on reference price drugs
Cost sharing mechanisms for fair pricing of resources usage
Transport Cost Sharing and Spatial Competition
Transport Cost Sharing and Spatial Competition
External reference pricing and the choice of country baskets and pricing rules
Cost sharing and clustering under distributed competition
Paths and Consistency in Additive Cost Sharing
Capacity rights and full cost transfer pricing
Capacity Rights and Full Cost Transfer Pricing
Complementarities, below-cost pricing, and welfare losses
Complementarities, below-cost pricing, and welfare losses
Cost sharing, capacity investment and pricing in networks
More cost-sharing, less cost? Evidence on reference price drugs
Cost sharing mechanisms for fair pricing of resources usage
Transport Cost Sharing and Spatial Competition
Transport Cost Sharing and Spatial Competition
External reference pricing and the choice of country baskets and pricing rules
Cost sharing and clustering under distributed competition
Paths and Consistency in Additive Cost Sharing
Capacity rights and full cost transfer pricing
Capacity Rights and Full Cost Transfer Pricing
Complementarities, below-cost pricing, and welfare losses
Complementarities, below-cost pricing, and welfare losses
Cost sharing, capacity investment and pricing in networks
More cost-sharing, less cost? Evidence on reference price drugs
Cost sharing mechanisms for fair pricing of resources usage
Transport Cost Sharing and Spatial Competition
Transport Cost Sharing and Spatial Competition
External reference pricing and the choice of country baskets and pricing rules
Cost sharing and clustering under distributed competition
Paths and Consistency in Additive Cost Sharing
Capacity rights and full cost transfer pricing
Capacity Rights and Full Cost Transfer Pricing
Complementarities, below-cost pricing, and welfare losses